Research and Application of Injectable Hydrogels

A special issue of Gels (ISSN 2310-2861). This special issue belongs to the section "Gel Applications".

Deadline for manuscript submissions: 30 November 2025 | Viewed by 702

Special Issue Editors


E-Mail Website
Guest Editor
Zhuhai UM Science & Technology Research Institute, University of Macau, Zhuhai 519099, China
Interests: hydrogel; self-assembly; polymer; cancer theranostics
Special Issues, Collections and Topics in MDPI journals
Institute of Materials Research and Engineering, Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Innovis #08-03, Singapore 138634, Singapore
Interests: biomaterials; materials chemistry; design and synthesis of biodegradable polymer; polymeric self-assemblies; biomedical materials; tissue engineering
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The field of injectable hydrogels has witnessed a remarkable surge in interest, driven by their unparalleled potential in biomedical applications. The following Special Issue, entitled "Research and Application of Injectable Hydrogels", is dedicated to exploring the multifaceted roles of these materials in tissue engineering, drug delivery, and regenerative medicine, with a particular focus on their innovative applications and underlying mechanisms.

In tissue engineering, injectable hydrogels have emerged as a transformative tool for the repair and regeneration of various tissues, including cartilage, bone, and soft tissues. Their ability to form a gel in situ, providing a scaffold for cell infiltration and proliferation, makes them an attractive option for minimally invasive procedures. The incorporation of bioactive molecules, growth factors, and cells within these hydrogels can further enhance their regenerative capabilities, leading to improved tissue function and integration.

The application of injectable hydrogels in drug delivery has opened new horizons for the treatment of various diseases. These materials can be engineered to encapsulate a wide range of therapeutic agents, from small molecules to proteins and nucleic acids, offering controlled release profiles tailored to the specific needs of the patient. The development of stimuli-responsive hydrogels that release drugs in response to internal or external cues, such as changes in pH, temperature, or the presence of specific enzymes, has the potential to significantly improve the efficacy and safety of drug therapies.

Furthermore, the use of injectable hydrogels in theranostics—combining therapy and diagnostics—represents a frontier in personalized medicine. By integrating imaging agents or diagnostic nanoparticles within the hydrogel matrix, it is possible to monitor the drug release process in real time, providing valuable feedback for treatment optimization. The versatility of injectable hydrogels extends to their tunable mechanical properties, which can be tailored to match the mechanical environment of the target tissue. This is particularly important for the successful integration of the hydrogel into the host tissue and for the prevention of adverse reactions.

In conclusion, injectable hydrogels are a class of materials that hold immense promise for advancing the fields of tissue engineering and drug delivery. Their unique properties, including their biocompatibility, biodegradability, and ability to be functionalized with a variety of bioactive agents, make them invaluable in the quest for innovative and effective medical treatments. We warmly invite researchers to contribute to this Special Issue, sharing their groundbreaking research that will undoubtedly shape the future of injectable hydrogel technology and its impact on human health.

Dr. Hongwei Cheng
Dr. Zibiao Li
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Gels is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2100 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • injectable hydrogel
  • biomechanics drug delivery
  • stimuli-responsive hydrogel
  • theranostics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

14 pages, 842 KB  
Review
Biological Augmentation of Meniscal Repair: A Review with Insights into Injectable Hydrogel Delivery
by Marta Tuszynska, Joanna Skopinska-Wisniewska and Anna Bajek
Gels 2025, 11(10), 786; https://doi.org/10.3390/gels11100786 - 1 Oct 2025
Abstract
Meniscal injuries are common and often lead to chronic pain, joint instability, and an increased risk of osteoarthritis. Traditional treatments, such as partial meniscectomy, may accelerate joint degeneration. In recent years, biologically active therapies, including platelet-rich plasma (PRP), mesenchymal stem cells (MSCs), hyaluronic [...] Read more.
Meniscal injuries are common and often lead to chronic pain, joint instability, and an increased risk of osteoarthritis. Traditional treatments, such as partial meniscectomy, may accelerate joint degeneration. In recent years, biologically active therapies, including platelet-rich plasma (PRP), mesenchymal stem cells (MSCs), hyaluronic acid (HA), bone marrow aspirate concentrate (BMAC), collagen, growth factors (GFs), and silk fibroin (SF), have emerged as promising strategies to enhance meniscal healing. This review evaluates the efficiency of these biological agents in promoting meniscal repair, with a particular focus on their potential integration into injectable hydrogel systems for targeted, minimally invasive delivery. Recent literature from 2015 to 2025 has provided growing insights into the role of biologically active agents and biomaterials in meniscal repair. Among the agents studied, PRP, MSCs, and HA have shown particular promise in modulating inflammation and supporting tissue regeneration. While biological therapies alone may not replace surgery for complex tears, they offer promising, less invasive alternatives that support tissue preservation. However, variability in study design, agent quality, and treatment protocols remains challenging. Further long-term research will be essential to confirm clinical benefits and optimize hydrogel-based delivery methods. Full article
(This article belongs to the Special Issue Research and Application of Injectable Hydrogels)
Show Figures

Figure 1

Back to TopTop